found a highly significant median overall survival in favorable CTC counts vs. patients with unfavorable CTC counts with metastatic breast cancer, metastatic colorectal cancer, and prostate cancer ( p < 0.0001).
← all excerpts
The Potential for Circulating Tumor Cells in Pancreatic Cancer Management.
1
—
—